{"date":"2025-08-25","count":19,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4745-2025-08-25-2118-6j0u7a","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2025-08-25","time":"21:18:49","subject":"依「公開發行公司資金貸與及背書保證處理準則」第25條第1項第4款公告相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2025-08-25 21:18，「依「公開發行公司資金貸與及背書保證處理準則」第25條第1項第4款公告相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2025-08-25-2118-1eg7fsl","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2025-08-25","time":"21:18:33","subject":"公告本公司集團間資金貸與達「公開發行公司資金貸與及背書保證處理準則」第22條第1項第3款相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2025-08-25 21:18，「公告本公司集團間資金貸與達「公開發行公司資金貸與及背書保證處理準則」第22條第1項第3款相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2025-08-25-2117-1eg7fsl","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2025-08-25","time":"21:17:54","subject":"公告本公司集團間資金貸與達「公開發行公司資金貸與及背書保證處理準則」第22條第1項第3款相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2025-08-25 21:17，「公告本公司集團間資金貸與達「公開發行公司資金貸與及背書保證處理準則」第22條第1項第3款相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2025-08-25-2117-1sm5xbj","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2025-08-25","time":"21:17:24","subject":"公告本公司集團間資金貸與達「公開發行公司資金貸與及背書保證處理準則」第22條第1項第1款相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2025-08-25 21:17，「公告本公司集團間資金貸與達「公開發行公司資金貸與及背書保證處理準則」第22條第1項第1款相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2025-08-25-2117-phgod7","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2025-08-25","time":"21:17:04","subject":"公告本公司之子公司合富(中國)醫療科技股份有限公司，擬投資明基醫院集團股份有限公司股權案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2025-08-25 21:17，「公告本公司之子公司合富(中國)醫療科技股份有限公司，擬投資明基醫院集團股份有限公司股權案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2025-08-25-2111-1s9b9mb","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2025-08-25","time":"21:11:17","subject":"公告本公司之子公司Cowealth Holding Co., Ltd.辦理解散清算事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2025-08-25 21:11，「公告本公司之子公司Cowealth Holding Co., Ltd.辦理解散清算事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2025-08-25-2110-458mon","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2025-08-25","time":"21:10:50","subject":"公告本公司之子公司合富投資股份有限公司、杰立投資股份有限公司辦理解散清算事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2025-08-25 21:10，「公告本公司之子公司合富投資股份有限公司、杰立投資股份有限公司辦理解散清算事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2025-08-25-2110-g0mtjm","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2025-08-25","time":"21:10:23","subject":"代重要子公司合富（中國）醫療科技股份有限公司公告董事會通過各項議案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2025-08-25 21:10，「代重要子公司合富（中國）醫療科技股份有限公司公告董事會通過各項議案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2025-08-25-2109-dnfegj","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2025-08-25","time":"21:09:55","subject":"公告本公司董事會通過財務主管、會計主管異動案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2025-08-25 21:09，「公告本公司董事會通過財務主管、會計主管異動案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2025-08-25-2109-140kqs7","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2025-08-25","time":"21:09:18","subject":"公告本公司董事會通過114年度第二季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2025-08-25 21:09，「公告本公司董事會通過114年度第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2025-08-25-1837-15bm7r6","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2025-08-25","time":"18:37:19","subject":"更正本公司114年第二季合併財務報告iXBRL申報資訊，此更正對財務報告損益並無影響。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2025-08-25 18:37，「更正本公司114年第二季合併財務報告iXBRL申報資訊，此更正對財務報告損益並無影響。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4157-2025-08-25-1729-8mmnt7","company_id":"4157","company":"太景*-KY","market":"上櫃","industry":"生技醫療","date":"2025-08-25","time":"17:29:09","subject":"公告補正本公司113年度年報部份內容(股東會後修訂本)","clause":"第50款","fact_date":"2025-08-25","cite_as":"公開資訊觀測站重大訊息：太景*-KY（4157），2025-08-25 17:29，「公告補正本公司113年度年報部份內容(股東會後修訂本)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6617-2025-08-25-1726-1kbupvl","company_id":"6617","company":"共信-KY","market":"上櫃","industry":"生技醫療","date":"2025-08-25","time":"17:26:04","subject":"公告修正本公司113年度股東會年報部分內容","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：共信-KY（6617），2025-08-25 17:26，「公告修正本公司113年度股東會年報部分內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8432-2025-08-25-1653-2n1wpr","company_id":"8432","company":"東生華","market":"上櫃","industry":"生技醫療","date":"2025-08-25","time":"16:53:17","subject":"公告更正本公司113年度股東會年報部分內容","clause":"第50款","fact_date":"2025-08-25","cite_as":"公開資訊觀測站重大訊息：東生華（8432），2025-08-25 16:53，「公告更正本公司113年度股東會年報部分內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4128-2025-08-25-1633-p67uuk","company_id":"4128","company":"中天","market":"上櫃","industry":"生技醫療","date":"2025-08-25","time":"16:33:10","subject":"公告本公司內部稽核主管異動","clause":"第8款","fact_date":"2025-08-25","cite_as":"公開資訊觀測站重大訊息：中天（4128），2025-08-25 16:33，「公告本公司內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6612-2025-08-25-1541-n25l4f","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2025-08-25","time":"15:41:57","subject":"代重要子公司MILLENNIUM BIOMEDICAL, INC.公告董事會決議發放現金股利。","clause":"第14款","fact_date":"2025-08-20","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2025-08-25 15:41，「代重要子公司MILLENNIUM BIOMEDICAL, INC.公告董事會決議發放現金股利。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2025-08-25-1518-1ol3y2x","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2025-08-25","time":"15:18:35","subject":"公告本公司股票初次上市現金增資委託代收及存儲價款機構","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2025-08-25 15:18，「公告本公司股票初次上市現金增資委託代收及存儲價款機構」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4192-2025-08-25-1345-1lmv9jb","company_id":"4192","company":"杏國","market":"上櫃","industry":"生技醫療","date":"2025-08-25","time":"13:45:21","subject":"公告補正本公司113年度股東會年報部分內容","clause":"第50款","fact_date":"2025-08-25","cite_as":"公開資訊觀測站重大訊息：杏國（4192），2025-08-25 13:45，「公告補正本公司113年度股東會年報部分內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4175-2025-08-25-1144-1lmv9jb","company_id":"4175","company":"杏一","market":"上櫃","industry":"生技醫療","date":"2025-08-25","time":"11:44:53","subject":"公告補正本公司113年度股東會年報部分內容","clause":"第50款","fact_date":"2025-08-25","cite_as":"公開資訊觀測站重大訊息：杏一（4175），2025-08-25 11:44，「公告補正本公司113年度股東會年報部分內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}